Gastric Plication and Duodenal-Jejunal Bypass Liner Implantation Reduce Systemic and Adipose Tissue Inflammation without Affecting Circulating Lipopolysaccharide Levels In Obese Subjects with Type 2 Diabetes Mellitus

被引:0
|
作者
Cinkajzlova, Anna
Lacinova, Zdenka
Klouckova, Jana
Kavalkova, Petra
Kratochvilova, Helena
Trachta, Pavel
Krizova, Jarmila
Dolezalova, Karin
Fried, Martin
Benes, Marek
Vlasakova, Zuzana
Pelikanova, Terezie
Mraz, Milos
Haluzik, Martin
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2151-P
引用
收藏
页码:A564 / A564
页数:1
相关论文
共 50 条
  • [1] Expression of Lipolysis-related Genes in Subcutaneous Adipose Tissue of Obese Subjects with Type 2 Diabetes Mellitus: The Influence of Gastric Plication and Duodenal-Jejunal Bypass Liner Implantation
    Klouckova, Jana
    Mraz, Milos
    Lacinova, Zdenka
    Kavalkova, Petra
    Cinkajzlova, Anna
    Trachta, Pavel
    Matoulek, Martin
    Svacina, Stepan
    Haluzik, Martin
    DIABETES, 2015, 64 : A562 - A562
  • [2] CD163+and CD206+adipose tissue immune cells in obese subjects with type 2 diabetes mellitus: the effect of gastric plication and duodenal-jejunal bypass liner implantation
    Cinkajzlova, A.
    Lacinova, Z.
    Klouckova, J.
    Kavalkova, P.
    Trachta, P.
    Mraz, M.
    Haluzik, M.
    DIABETOLOGIA, 2015, 58 : S49 - S49
  • [3] CD163+and CD206+Adipose Tissue Macrophage Subpopulations in Subjects with Obesity and Type 2 Diabetes Mellitus: The Effect of Gastric Plication and Duodenal-Jejunal Bypass Liner Implantation
    Cinkajzlova, Anna
    Lacinova, Zdenka
    Klouckova, Jana
    Kavalkova, Petra
    Trachta, Pavel
    Mraz, Milos
    Haluzik, Martin
    DIABETES, 2015, 64 : A572 - A572
  • [4] Improvement of Type 2 Diabetes after Implantation of a Duodenal-Jejunal Bypass Liner in Obese Patients
    Betzel, B.
    Koehestanie, P.
    Dogan, K.
    Janssen, I.
    Wahab, P.
    Berends, F.
    de Boer, H.
    OBESITY SURGERY, 2013, 23 (08) : 1179 - 1180
  • [5] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitus in Morbidly Obese Patients
    Rodrigo Muñoz
    Alex Escalona
    Current Cardiology Reports, 2014, 16
  • [6] Implantation of an endoscopically deployed Duodenal-Jejunal Bypass Liner in obese type 2 diabetes subjects: 8 months follow up of ten subjects
    Krepak, Y.
    Stratmann, B.
    Hauber, M.
    Lee-Barkey, Y. H.
    Fischer, M.
    Tschoepe, D.
    DIABETOLOGIA, 2013, 56 : S293 - S293
  • [7] Endoscopic Duodenal-Jejunal Bypass Liner (EndoBarrier®) for the treatment of type 2 diabetes mellitus
    Laubner, K.
    Perakakis, N.
    Potasso, L.
    Schwacha, H.
    Seufert, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [8] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitusin Morbidly Obese Patients
    Munoz, Rodrigo
    Escalona, Alex
    CURRENT CARDIOLOGY REPORTS, 2014, 16 (03)
  • [9] ENDOSCOPICALLY DELIVERED DUODENAL-JEJUNAL BYPASS LINER TO TREAT TYPE 2 DIABETES IN OBESE PATIENTS
    Curcio, G.
    Casu, A.
    Traina, M.
    Colanino, M. Ziino
    Tuzzolino, F.
    Vizzini, G.
    Gridelli, B.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S143 - S143
  • [10] The Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review
    Zechmeister-Koss, Ingrid
    Huic, Mirjana
    Fischer, Stefan
    OBESITY SURGERY, 2014, 24 (02) : 310 - 323